Emerging Technologies Promise Revolutionary Diagnostic Tools
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read MorePosted by Elaine Sanchez Wilson | Apr 3, 2015 | Cancer, Heart Disease, Molecular Diagnostics |
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read MorePosted by Elaine Sanchez Wilson | Apr 2, 2015 | Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Urinalysis & Toxicology |
Featured chemistry and integrated analyzers include the Arkray Aution Hybrid AU-4050 analyzer system from US Arkray Inc, the Advia Chemistry XPT system from Siemens Healthcare, and the Cobas 8000 analyzer series from Roche Diagnostics.
Read MorePosted by Elaine Sanchez Wilson | Apr 2, 2015 | Diabetes & Metabolic Diseases |
A finely tuned set of orders for intravenous insulin infusions in hospitalized diabetic patients, the Portland Diabetes Protocols have been successfully used at institutions throughout the world to control hyperglycemia.
Read MorePosted by Elaine Sanchez Wilson | Apr 2, 2015 | Clinical Chemistry |
In critical care settings, tight glucose control is not just for diabetics.
Read MorePosted by Jenny Lower | Mar 3, 2015 | Cancer |
Experts from the clinical lab community gathered on January 8–9, 2015, to comment on FDA’s proposed regulatory structure for laboratory-developed tests. This selection of comments from the first day of the workshop offers a glimpse into the depth of participants’ observations.
Read More